Laureates of Kiyoko Goto and Paul Bourdarie Scientific Prize

Laureates by year

The 1st (2012) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Dr. Manabu SODA
Postdoctoral fellow, Division of Functional Genomics, Center for Molecular Medicine, Jichi Medical University
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer (Nature 2007)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award

Dr. Ryogo MINAMIMOTO
Doctor, Division of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine
4’-[Methyl-11C]-Thiothymidine PET/CT for Proliferation Imaging in Non–Small Cell Lung Cancer (Journal of Nuclear Medicine 2012)

The 2nd (2013) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Dr. Makoto MAEMONDO
Medical Director, Miyagi Cancer Center
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR(N Engl J Med 2010; 362: 2380-8)
Kiyoko Goto and Paul Bourdarie Scientific Prize

Dr. Tetsuya MITSUDOMI
Professor, Department of Respiratory Surgery, Department of Surgery, Kinki University Faculty of Medicine
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial(Lancet Oncol 2010;11:121-28)

The 3rd (2014) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Dr. Kota KATANODA
Chief of Division of Cancer Statistics Integration, Center for Cancer Control and Information Services, National Cancer Center Japan
Population attributable fraction of mortality associated with tobacco smokingin Japan: a pooled analysis of three large-scale cohort studies(Journal of Epidemiology, 2008; 18:251-64)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award

Dr. Yukinori MATSUO
Senior Lecturer, Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University
Evaluation of dynamic tumour tracking radiotherapy with real-time monitoring for lung tumours using a gimbal mounted linac(Radiother Oncol. 2014;112:360-4.)

The 4th (2015) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Kengo TAKEUCHI M.D., Ph.D.
Project Leader, Pathology Project for Molecular Targets, The Cancer Institute of Japanese Foundation for Cancer Research
RET, ROS1 and ALK fusions in lung cancer(Nat Med. 2012;18:378-381)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award

Yu FUJITA M.D., Ph.D.
Specially Appointed Researcher, Division of Molecular and Cellular Medicine, National Cancer Center Research Institute. (Research Associate, Division of Respiratory Diseases, Jikei University School of Medicine)
A novel platform to enable inhaled naked RNAi medicine for lung cancer (Scientific Reports, 2013 Nov 25 ;3 :3325.)

The 5th (2016) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Hidemi ITO M.D., Ph.D., M.P.H
Section Chief of Division of Molecular Medicine, Aichi Cancer Center Research Institute
Non-filter and filter cigarette consumption and the incidence of lung cancer hy histological type in Japan and the United States: analysis of 30-year data from population-based cancer registries. (International Journal of Cancer. 201L 128(8): 1918-28.)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award

Koichi TAKAYAMA M.D., Ph.D.
Professor, Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial (Support Care Cancer 2016 Aug;24(8):3495‐ 505)

The 6th (2017) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Takahiro TABUCHI M.D., Ph.D.
Associate Chief, Department of Cancer Epidemiology, Cancer Control Center, Osaka International Cancer Institute
Tobacco smoking and the risk of subsequent primary cancer among cancer survivors: a retrospective cohort study (Annals of Oncology, 2013;24(10):2699-704)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award

Shimpei KUBOTA M.D.,Ph.D.
Postdoctoral Fellow of Japan Society for the Promotion of Science, Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo
Whole-Body Profiling of Cancer Metastasis with Single-Cell Resolution (Cell Reports, 2017, 20, 236-250)
Kei TAKAHASHI Ph.D.
Project Researcher, Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo

The 7th (2018) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Tadashi AKIBA, M.D., Ph.D.
Executive Director, The Jikei University Chief, The Jikei University Kashiwa Hospital Professor, Division of Thoracic Surgery, Department of Surgery, Graduate School of Medicine, The Jikei University
Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial (Clinical Cancer Research, 2018 Sep 1;24(17):4089-4097)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award

Sachie HIRATSUKA-NAKAMURA, M.D., Ph.D.
Professor, Department of Biochemistry and Molecular Biology, Shinshu University School of Medicine
Hepato-entrained B220+CD11c+NK1.1+cells regulate pre-metastatic niche formation in the lung(EMBO Molecular Medicine, 2018; 10: e8643)

The 8th (2019) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Masahito SHIMOJO, Ph.D.
Specially Appointed Associate Professor, Graduate School of Pharmaceutical Sciences, Osaka University
A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer (Scientific Reports volume 9, Article number: 7618 (2019))
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award

Yujin KUDO, M.D., Ph.D.
Assistant Professor, Department of Thoracic Surgery, Tokyo Medical University
Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non small cell lung cancer (Annals of Oncology, 2019 Sep 1;30(9):1521-1530)

The 9th (2020) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Kenichi YOSHIDA, M.D., Ph.D.
Wellcome Sanger Institute / Postdoctoral fellow
Tobacco smoking and somatic mutations in human bronchial epithelium (Nature. 2020;578;266-272.)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award

Kenji CHAMOTO, Ph.D.
Department of Immunology and Genomic Medicine Kyoto University Graduate School of Medicine / Associate professor
Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy. (JCI Insight. 2020 Jan 30; 5(2): e133501.Published online 2020 Jan 30.)

The 10th (2021) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Kazuhito FUNAI, M.D., Ph.D.
Associate professor, First Department of Surgery, Hamamatsu University School of Medicine
Urinary Fluorescent Metabolite O-Aminohippuric Acid is a Useful Biomarker for Lung Cancer Detection (Metabolomics、2020 Sep 17;16(10):101. )
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award

Taiki HAKOZAKI, M.D.
Staff Physician, Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer (Cancer Immunol Res. 2020;8(10):1243-1250.)

The 11th (2022) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Hisashi SAJI, M.D., Ph.D.
Professor & Chair, Department of Thoracic Surgery, St. Marianna University School of Medicine
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial (Lancet. 2022 Apr 23;399(10335):1607-1617.)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award

Hiroshi ICHISE, Ph.D.
Visiting fellow, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Functional visualization of NK cell-mediated killing of metastatic single tumor cells (eLife, 2022; 11, e76269 (1-28))
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award

Yoshihisa KOBAYASHI, M.D., Ph.D.
Staff Scientist, Division of Molecular Pathology, National Cancer Center Research Institute
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers. (Nature 2022; 603(7900):335-342.)

The 12th (2023) laureate

Laureates Paper
Kiyoko Goto and Paul Bourdarie Scientific Prize

Kentaro TANAKA, M.D., Ph.D.
Associate Professor, Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University (position on April 1st 2024, Associate Professor, Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University)
Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer (Science Translational Medicine 2022;14 (675):eabq0021)
Kiyoko Goto and Paul Bourdarie Scientific Prize

Fumihiro SHOJI, M.D., Ph.D.
Chief of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center
Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer (Frontiers in Molecular Bioscience 2022, 9:1040424)

PAGE TOP